Caris Life Sciences, Inc. (CAI)
19.29
+0.16
(+0.84%)
USD |
NASDAQ |
Apr 02, 16:00
19.28
0.00 (0.00%)
After-Hours: 20:00
Caris Life Sciences Market Cap : 5.487B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Neurocrine Biosciences, Inc. | 13.11B |
| Glaukos Corp. | 6.554B |
| Edgewise Therapeutics, Inc. | 3.595B |
| Nuvalent, Inc. | 8.272B |
| Alphatec Holdings, Inc. | 1.577B |
Market Cap Related Metrics
| PS Ratio | 6.746 |
| PEG Ratio | -0.2396 |
| Price to Book Value | 9.504 |
| Price to Free Cash Flow | 92.56 |
| Price | 19.29 |
| Earnings Yield | -9.85% |
| PEGY Ratio | -0.2396 |
| Operating PE Ratio | 121.43 |